Supernus Pharmaceuticals, Inc. (SUPN)

NGM – Real vaqt narxi. Valyuta: USD

47.87

+0.99 (2.11%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

47.87

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:04 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Supernus Pharmaceuticals, Inc. (SUPN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Supernus Pharmaceuticals, Inc. (SUPN)

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

New Strong Buy Stocks for August 7th

Best Value Stocks to Buy for August 7th

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Why Supernus Pharmaceuticals Stock Topped the Market Today

Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript

Videolar

No Data

Press-relizlar

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Search stocks

Supernus Pharmaceuticals, Inc. (SUPN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Supernus Pharmaceuticals, Inc. (SUPN)

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

New Strong Buy Stocks for August 7th

Best Value Stocks to Buy for August 7th

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Why Supernus Pharmaceuticals Stock Topped the Market Today

Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript

Videolar

No Data

Press-relizlar

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders